Ronald Intini
Family Medicine · Wendell, NCNPI 1841397858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 489 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,481 and has fallen 62.9% since, to $1,290 in 2022. Among family medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 489 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$931
- Amgen$910
- GSK$865
- Amarin Pharma, Inc.$720
- AbbVie$567
- plus $3K from 25 others
What the payments were for
- Food & beverage$8,966100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 120 | $1,901 |
| AstraZeneca | 26 | $931 |
| Amgen | 48 | $910 |
| GSK | 42 | $865 |
| Amarin Pharma, Inc. | 36 | $720 |
| AbbVie(2 entities) | 32 | $567 |
| Sanofi-aventis U.S. LLC | 23 | $391 |
| Boehringer Ingelheim | 24 | $386 |
| Lilly USA, LLC | 30 | $376 |
| Esperion Therapeutics, Inc. | 10 | $343 |
| Pfizer | 13 | $294 |
| Merck | 17 | $243 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $192 |
| Novartis | 10 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $99 |
| Johnson & Johnson | 7 | $97 |
| Astellas Pharma US Inc | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Abbott | 2 | $48 |
| Mylan Specialty L.p. | 3 | $46 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 3 | $40 |
| Kowa Pharmaceuticals America, Inc. | 3 | $40 |
| Genentech USA, Inc. | 2 | $28 |
| Bayer | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,966 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Wendell
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.